​

Cidara Therapeutics Ownership | Who Owns Cidara Therapeutics?

OverviewForecastFinancialsChartTranscripts

Cidara Therapeutics Ownership Summary

Cidara Therapeutics is owned by 55.84% institutional investors, 0.46% insiders, and 43.70% retail investors. Bain capital life sciences investors is the largest institutional shareholder, holding 19.43% of CDTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.55% of its assets in Cidara Therapeutics shares.

CDTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCidara Therapeutics55.84%0.46%43.70%
SectorHealthcare Stocks 35.34%11.88%52.77%
IndustryBiotech Stocks 35.37%11.83%52.80%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bain capital life sciences investors3.02M19.43%$289.29M
Vanguard group2.01M12.91%$443.37M
Bvf inc/il1.41M9.10%$135.42M
Vr adviser946.79K6.09%$90.66M
Commodore capital lp585.00K3.76%$56.02M
Holocene advisors, lp487.23K3.13%$46.66M
Vestal point capital, lp400.00K2.57%$38.30M
Ubs oconnor315.47K2.03%$69.69M
Samlyn capital307.96K1.98%$29.49M
First light asset management292.66K1.88%$28.02M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bain capital life sciences investors3.02M19.20%$289.29M
Ubs oconnor315.47K8.12%$69.69M
Bvf inc/il1.41M5.49%$135.42M
Vr adviser946.79K5.10%$90.66M
Stempoint capital lp152.32K2.92%$14.59M
Commodore capital lp585.00K2.73%$56.02M
First light asset management292.66K2.64%$28.02M
Vestal point capital, lp400.00K1.73%$38.30M
Sphera funds management75.74K1.53%$7.25M
Catalio capital management, lp53.33K0.94%$5.11M

Top Buyers

HolderShares% AssetsChange
Vanguard group2.01M0.01%776.53K
Bvf inc/il1.41M5.49%627.77K
Bain capital life sciences investors3.02M19.20%520.31K
Holocene advisors, lp487.23K0.11%487.23K
Ubs oconnor315.47K8.12%315.47K

Top Sellers

HolderShares% AssetsChange
Ra capital management---3.37M
Blackrock funding, inc. /de---1.68M
Hbk investments l p---1.26M
Fil---1.26M
5am venture management---1.13M

New Positions

HolderShares% AssetsChangeValue
Holocene advisors, lp487.23K0.11%487.23K$46.66M
Ubs oconnor315.47K8.12%315.47K$69.69M
Samlyn capital307.96K0.41%307.96K$29.49M
Norges bank200.00K0.00%200.00K$44.18M
J. goldman & co lp138.09K0.33%138.09K$13.22M

Sold Out

HolderChange
Northwestern mutual wealth management-1.00
Sjs investment consulting-1.00
Tortoise investment management-1.00
Bell investment advisors-2.00
Marquette asset management-2.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202597-45.81%8,681,954-73.28%550.13%78-36.59%15-50.00%
Sep 30, 202556-53.72%4,347,245-83.22%270.10%41-58.16%928.57%
Jun 30, 2025121163.04%25,911,048172.67%1663.71%98262.96%7-22.22%
Mar 31, 20254720.51%9,559,38739.46%670.58%27-10.00%9200.00%
Dec 31, 20243944.44%6,854,593107.19%1074.21%30100.00%3-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv592.28K2.55%-13.13K
iShares Russell 2000 ETF404.28K1.59%-
Vanguard US Total Market Shares ETF121.55K1.11%-
abrdn Healthcare Investors179.90K0.71%-
Vanguard Institutional Extnd Mkt Idx Tr159.67K0.69%-69.89K
Fidelity Small Cap Index168.54K0.66%168.54K
iShares Russell 2000 Value ETF147.78K0.58%-
Fidelity Select Health Care140.00K0.55%140.00K
State St Russell Sm/Mid Cp® Indx SL Cl I93.02K0.42%72.02K
Invesco Dorsey Wright SmallCap Momt ETF104.73K0.41%136.00

Recent Insider Transactions

DateNameRoleActivityValue
Mar 31, 2017Stein Jeffrey President & CEOBuy$99.97K
Sep 12, 2017Stein Jeffrey President & CEOBuy$49.84K
Nov 10, 2020Stein Jeffrey President & CEOBuy$100.02K
Jun 05, 2017Stein Jeffrey President & CEOBuy$89.21K
Dec 10, 2025Ward Shane COO & CLOSell$2.19M

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q4-1
2025 Q3-1
2025 Q23-
2025 Q1-2

CDTX Ownership FAQ

Who Owns Cidara Therapeutics?

Cidara Therapeutics shareholders are primarily institutional investors at 55.84%, followed by 0.46% insiders and 43.70% retail investors. The average institutional ownership in Cidara Therapeutics's industry, Biotech Stocks , is 35.37%, which Cidara Therapeutics exceeds.

Who owns the most shares of Cidara Therapeutics?

Cidara Therapeutics’s largest shareholders are Bain capital life sciences investors (3.02M shares, 19.43%), Vanguard group (2.01M shares, 12.91%), and Bvf inc/il (1.41M shares, 9.10%). Together, they hold 41.44% of Cidara Therapeutics’s total shares outstanding.

Does Blackrock own Cidara Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cidara Therapeutics.

Who is Cidara Therapeutics’s biggest shareholder by percentage of total assets invested?

Bain capital life sciences investors is Cidara Therapeutics’s biggest shareholder by percentage of total assets invested, with 19.20% of its assets in 3.02M Cidara Therapeutics shares, valued at 289.29M$.

Who is the top mutual fund holder of Cidara Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cidara Therapeutics shares, with 2.55% of its total shares outstanding invested in 592.28K Cidara Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools